Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin

To assess the efficacy and safety of an experimental course of antiviral therapy with recombinant IL-1β in combination with recombinant interferon-α2b and ribavirin in patients with chronic hepatitis C infected with genotype 1 hepatitis C virus in lacking the virologic response to previous dual ther...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. V. Lobzin, K. V. Zhdanov, A. S. Simbirtsev, A. A. Yakovlev, S. N. Kizhlo, V. H. Fazilov, S. N. Zharov, M. F. Lebedev
Format: Article
Language:Russian
Published: Journal Infectology 2014-09-01
Series:Журнал инфектологии
Subjects:
chronic viral hepatitis c
antiviral therapy
efficacy
safety
interferon
il-1β
Online Access:https://journal.niidi.ru/jofin/article/view/137
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items